[CAS NO. 354812-17-2]  SC-514

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [354812-17-2]

Store
Catalog
SLK-S4907
Brand
Selleck
CAS
354812-17-2

DESCRIPTION [354812-17-2]

Overview

MDLMFCD00206459
Molecular Weight224.3
Molecular FormulaC9H8N2OS2
SMILESC(N)(=O)C=1SC(=CC1N)C=2C=CSC2

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM4.4583 mL22.2916 mL44.5831 mL
5 mM0.8917 mL4.4583 mL8.9166 mL
10 mM0.4458 mL2.2292 mL4.4583 mL
50 mM0.0892 mL0.4458 mL0.8917 mL

Description

SC-514 (GK 01140) is an orally active, ATP-competitive inhibitor with of 3-12 μM, blocks -dependent gene expression, does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases.

Targets

IKK2 [1]CDK2/CyclinA [1]AUR2 [1]PRAK [1]MSK [1]
3 μM-12 μM61 μM 71 μM75 μM123 μM

In vitro

SC-514 inhibits the native IKK complex or recombinant human IKK-1/IKK-2 heterodimer and IKK-2 homodimer similarly. SC-514 inhibits transcription of NF-κB-dependent IL-6, IL-8, and COX-2 genes in IL-1β-induced rheumatoid arthritis-derived synovial fibroblasts (RASFs) with IC50s of 20, 20 and 8 μM. 100 μM SC-514 blocks the phosphorylation and degradation of IκBα and also reduces the level of translocation of p65 into the nucleus in IL-1β-treated RASFs SC-514 does not inhibit the phosphorylation and activation of the IKK complex. SC-514 induces a delay but not a complete blockade in IκBα phosphorylation and degradation. SC-514 treatment cells shows a slightly slowed, decreased import of p65 into the nucleus and a faster export of p65 from the nucleus. SC-514 inhibits the phosphorylation of either IκBα or p65 similarly.

In vivo

SC-514 is efficacious in an acute model of inflammation, namely LPS-induced serum TNF-α production. SC-514 (50 mg/kg, i.p.) inhibits TNF-αproduction in vivo by ~70%.


Synonyms

[2,3′-Bithiophene]-5-carboxamide, 4-amino-
4-Amino[2,3′-bithiophene]-5-carboxamide
4-Amino-[2,3′]bithiophenyl-5-carboxamide
3-Amino-5-(3-thienyl)thiophene-2-carboxamide
SC 514
GK 01140
3-Amino-5-thiophen-3-ylthiophene-2-carboxamide
3-Amino-5-(thiophen-3-yl)thiophene-2-carboxamide